Marrone Bio Improvements’ BioUnite™ program affords new options to California growers

[ad_1]

BioUnite program allows California grape and almond growers to deal with mid-season pest administration wants

DAVIS, Calif., July 9, 2019 – Marrone Bio Improvements Inc. (the “Firm” or “MBI”) (NASDAQ: MBII), a number one developer of bio-based merchandise for pest administration and plant well being, immediately introduced that California almond and grape growers are gaining an edge as they handle mid-season pest management points by the implementation of the corporate’s novel BioUnite program.

Marrone Bio launched BioUnite to offer growers with built-in pest administration applications that harness the ability of biology with the efficiency of chemistry leading to a extra environment friendly meals manufacturing system that’s reasonably priced, sustainable, protected, and simple to make use of. BioUnite offers particular organic prescriptions that growers combine into their operations, taking the guesswork out of utilizing biologically derived supplies with their customary crop safety program.

Marrone Bio helps the BioUnite program with analysis that spans from preliminary discoveries by hands-on area trials. Almond growers are at present treating for navel orangeworm larvae, which bore into and eat the nut fruit, damaging high quality, and yield, and lowering the worth farmers obtain for his or her crop. In in depth 2018 area trials, Marrone Bio Improvements’ Venerate® organic insecticide, when tank blended with a typical insecticide, diminished nut injury by an extra 2% as in contrast with the usual insecticide program. This Venerate BioUnite program leads to a 6-to-1 return on funding to the grower. In grapes, the BioUnite idea integrates Haven® plant stress supervisor into the grower vine administration program. Area trials demonstrated Haven resulted in an 18% yield enhance, delivering a 6-to-1 return on funding. Additionally in grapes, when Regalia® biofungicide was added to the  growers’ illness administration program, Regalia supplied a 57% enchancment in illness management as in comparison with the usual remedy.

“Growers world wide are confronted with the problem to satisfy various shopper calls for for larger alternative, affordability, and availability,” mentioned Kevin Hammill, Chief Industrial Officer for Marrone Bio Improvements. “Growers want progressive, cost-effective instruments to function in a dynamic, altering market. We imagine that BioUnite affords growers an thrilling new useful resource to satisfy shopper calls for,” concluded Hammill.

About Marrone Bio Improvements

Marrone Bio Improvements Inc. (NASDAQ: MBII) is a growth-oriented firm main the motion to extra a sustainable world by the invention, growth and sale of progressive organic merchandise for crop safety, plant well being and waterway programs remedy that assist prospects function extra sustainably whereas growing their return on funding. MBI has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth information of plant and soil microbiomes enhanced by superior molecular applied sciences and pure product chemistry to quickly develop seven product strains. Supported by a strong portfolio of over 400 issued and pending patents, MBI’s at present accessible industrial merchandise are Regalia®, Stargus®, Grandevo®, Venerate®, Majestene®, Haven® and Amplitude®, Zelto® and Zequanox®, with a breakthrough bioherbicide and biofumigant within the firm’s product pipeline.

Study extra about Marrone Bio Improvements at www.marronebio.com. Comply with us on social media: Twitter, LinkedIn and Instagram.

Marrone Bio Improvements Ahead-Trying Statements

This press launch accommodates forward-looking statements that contain substantial dangers and uncertainties. All statements, aside from statements of historic info, included on this press launch relating to technique, future operations and plans, together with assumptions underlying such statements, are forward-looking statements, and shouldn’t be relied upon as representing MBI’s views as of any subsequent date. Examples of such statements embrace the potential of MBI’s merchandise together with Venerate, Haven and Regalia in BioUnite applications and market projections. Such forward-looking statements are primarily based on data accessible to the Firm as of the date of this launch and contain quite a few dangers and uncertainties, some past the Firm’s management, that might trigger precise outcomes to vary materially from these anticipated by these forward-looking statements, together with climate, regulatory and different components affecting demand for the MBI’s merchandise, any issue in advertising MBI’s merchandise in its goal markets, competitors out there for pest administration merchandise, lack of expertise of bio-based pest administration merchandise by prospects and growers. Further data that might result in materials adjustments in MBI’s efficiency is contained in its filings with the SEC. MBI is below no obligation to, and expressly disclaims any accountability to, replace or alter forward-looking statements contained on this launch, whether or not on account of present data, future occasions or in any other case.

Marrone Bio Improvements Contact:
Kevin Hammill, Chief Industrial Officer
Phone: +1 (530) 750-2800
E mail: [email protected]

Investor Relations:
Greg Falesnik
Managing Director
MZ Group – MZ North America
Foremost: 949-385-6449
[email protected]
www.mzgroup.us



[ad_2]

Latest posts